BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 23, 2000
View Archived Issues
Meningococcal C conjugate vaccine shown to be safe and immunogenic in infants
Read More
Thrombopoietin preparation shows no clinical benefit in myeloid leukemia
Read More
Researchers repair gene mutation responsible for muscular dystrophy in dogs
Read More
New research strengthens link between COX-2 and angiogenesis/tumor growth
Read More
Celltech Group highlights recent advances for key products at annual general meeting
Read More
Tumor-associated antigen-derived immunogenic polypeptides useful for cancer immunotherapy
Read More
Antiplatelet compounds in early development at Welfide superior to cilostazol in activity, safety
Read More
Recent patent describes Galderma's latest series of vitamin D analogues
Read More
New compounds synthesized at Teijin favorably affect lipid profiles
Read More
Senju's new aldose reductase inhibitors have potential for diabetic complications
Read More
Daiichi commences development of new anticancer compound
Read More
Procyon's Q3 marked by progress on all fronts
Read More
Potent and safe analgesics derived from tramadol patented by Vita-Invest
Read More
Agents for use in BPH in development at Merck & Co.
Read More
Boehringer Ingelheim claims thrombin inhibitor series
Read More
Mechanism of apoptosis induction elucidated for NIK-333
Read More
BIIL-284: preclinical profile of a new, orally active LTB4 antagonist
Read More
Cardio- and neuroprotective effects of NCX-4016 highlighted at recent conference
Read More
Alexion highlights Q3 progress of five phase II trials with 5G1.1
Read More
Inhibitors of multiple leukotrienes in development for asthma at Czech research institute
Read More
PD-170292: a nonpeptide compound with full agonist activity at the high-affinity CCK1 site
Read More
Advanced Magnetics receives FDA action letter for Combidex contrast agent
Read More
NO-indomethacin derivative compares favorably with indomethacin regarding GI effects
Read More
HemispheRx Biopharma files marketing application in E.U. for Ampligen
Read More
Merck Frosst launches Varivax II for protection against chickenpox
Read More
Palatin Technologies to begin development of PT-141 for treatment of erectile dysfunction
Read More